ClinicalTrials.govpublic full text
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
multiple myeloma, myeloma, relapsed multiple myeloma, refractory multiple myeloma, relapsed or refractory multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860717
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.